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Hemoglobin (Hb) S is a β-chain structural variant of human hemoglobin that undergoes 
polymerization in its deoxygenated form, making red blood cells stiff and undeformable and 
causing hemolysis and vaso-occlusion, with tissue damage and pain. Heterozygotes (Hb AS) 
are generally asymptomatic, while homozygotes (Hb SS) have sickle cell anemia (SCA). 
Combinations of Hb S and other hemoglobin variants, such as Hb C and D, or β-thalassemia can 
produce clinical pictures similar to that of SCA and are known as sickle cell diseases (SCD)(1). 
Around 1 to 2% of the world’s population are Hb S heterozygotes, but in some regions of 
Africa that are endemic for malaria (against which Hb AS individuals are protected) the frequency 
of the bS gene can be greater than 40%(2). In Brazil, the Southeast and Northeast regions have the 
greatest prevalence (around 8% of individuals of African descent are heterozygotes), although 
in some populations, such as that in Salvador, Bahia, the prevalence can be higher than 10%(3,4). 
Correct diagnosis of this hemoglobinopathy is extremely important, particularly during 
the neonatal period, as early detection of SCD is fundamental if morbidity and mortality of these 
diseases are to be reduced. Laboratory diagnosis of SCD generally involves techniques based 
on the electric charge of the variants, such as cellulose acetate or gel electrophoresis, isoelectric 
focusing, high-performance liquid chromatography (HPLC) and capillary electrophoresis(5). 
However, as more than 1,000 variants have been described to date(6), the probability of finding 
another variant with electrophoretic behavior similar to that of Hb S (Hb S-like hemoglobins) 
is quite high, particularly in a population with a high degree of miscegenation, like that of 
Brazil. For this reason it is important to use confirmatory tests (which are also frequently used 
in screening programs), such as the sickling test and the hemoglobin solubility test (based 
on the insolubility of deoxy-HbS in high molarity phosphate buffer)(5). In the case of Hb S in 
association with other variants, whether Hb S-like or not, correct identification of the second 
variant is fundamental to distinguish between those variants that will lead to SCD, those 
that evolve without any symptoms and those that produce specific symptoms(7). Molecular 
techniques, such as restriction enzyme analysis and globin gene sequencing, are the most 
commonly used techniques for known mutations and new or rare mutations, respectively(8,9). 
It should also be mentioned that some Hb S-like variants can cause red blood cell sickling, 
hemolysis and vaso-occlusion even in a heterozygous state. Examples include Hb Jamaica 
Plain(10) and Hb S São Paulo(11), the latter recently described in the Brazilian population. It 
should also be stressed that Hb S in association with an Hb S-like hemoglobin can lead to an 
incorrect diagnosis of SCA if the appropriate confirmatory tests are not carried out(12).
And what are the Hb S-like variants in the Brazilian population? 
Some variants have a structural change in the β-chains, while in others the α-chains are 
affected. The former include Hbs D, Lepore, Korle-Bu, Osu-Christiansborg and Zürich(13,14), 
and the latter Hbs Hasharon, Stanleyville-II, G-Pest, Sunshine Seth, G-Philadelphia, West One and 
Daneshgah-Tehran(8,9,14). In the case of the α-chain variants, some technical characteristics can help 
with the diagnosis; these include the presence of four bands in electrophoresis - two corresponding 
to Hb A
2
 (A
2
 and A
2
’) and two to Hb A (A and ‘X’) - and a lower concentration of ‘Hb X’ than 
normally observed in individuals with β-chain variants. Some α-chain variants are associated with 
α-thalassemia, with concomitant microcytosis and hypochromia, as is the case with the Hasharon 
(Figure 1) and Stanleyville-II variants, the most common in the Brazilian population(8,15). 
Diagnosis during the neonatal period, however, involves further difficulties: the reduced 
concentration of α-chain variants makes it difficult to see the bands clearly, and the high 
concentration of fetal Hb (Hb F) interferes with confirmatory tests. The most commonly used 
screening methods in Brazil are isoelectric focusing and HPLC, followed by molecular biology 
techniques(16). In the National Neonatal Screening Program operated by the Brazilian national 
health system (SUS), the heel prick, which is carried out in most Brazilian maternity wards, 
is used to screen for SCD and other genetic diseases(1). With the aid of this screening program 
various α-chain variants have been detected, as the article published in this issue by Silva et al.(17), 
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belonging to the research group of Prof. Marcos Borato Viana, of 
the of the Pediatrics Department of the Universidade Federal de 
Minas Gerais (UFMG), shows us. The neonatal screening program 
run by the Nucleus of Actions and Research in Diagnosis at this 
university has helped to provide a greater understanding of the 
hemoglobinopathies found in different regions of Brazil - each 
one with its own ethnical characteristics and diversity - and has 
highlighted the importance of screening in itself and of correctly 
identifying other variants that can be confused with Hb S.
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Figure 1 – (a) Cellulose acetate electrophoresis at alkaline pH; (b) restriction analysis with Taq I to confirm Hb Hasharon
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